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Regulatory T (T reg) cells represent a class of 
T lymphocytes that serve to restrict the extent 
and duration of immune responses, as well as 
maintain self-tolerance by suppressing autoreac-
tive T cells (Shevach, 2000; Sakaguchi, 2004, 
2005; Fontenot and Rudensky, 2005; Ziegler, 
2006). Among the different types of T reg cells 
described to date, CD4+CD25+ cells that express 
the transcription factor Foxp3 are the most well 
characterized T cells with immune-suppressive 
properties (Fontenot and Rudensky, 2005; 
Sakaguchi, 2005; Ziegler, 2006). Most Foxp3+ 
CD4 T cells, referred to as CD4 T reg cells, be-
gin to develop in the thymus between 2 and 3 d 
after birth (Fontenot et al., 2005a). Like con-
ventional CD4+ T cells, thymus-derived 
CD4+Foxp3+ T cells (also known as natural 
T reg [nT reg] cells) undergo positive selection 
through TCR interactions with self-peptides 
presented by cortical thymic epithelial cells 
(Bensinger et al., 2001). Although conventional 
CD4 single-positive (SP) T cells that express 
TCRs with low to intermediate affinity for self-
peptides are selected to undergo maturation, and 
those with high-affinity TCRs are eliminated by 
negative selection (Robey and Fowlkes, 1994), 
T reg cells appear to develop from CD4 SP thy-
mocytes expressing TCRs with a relatively high 
affinity for self-antigens (Caton et al., 2004; 
Liston and Rudensky, 2007). In addition to 
TCR signals, costimulatory molecules and cyto-
kines, which include CD28 (Tang et al., 2003; 
Sansom and Walker, 2006) and IL-2 (Bayer 
et al., 2005; Fontenot et al., 2005b), respectively, 
contribute to the development of nT reg cells. 
Consistent with multiple signals being required 
for nT reg cell development, disrupting various 
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During thymopoiesis, a unique program of gene expression promotes the development of 
CD4 regulatory T (T reg) cells. Although Foxp3 maintains a pattern of gene expression 
necessary for T reg cell function, other transcription factors are emerging as important 
determinants of T reg cell development. We show that the NF-B transcription factor  
c-Rel is highly expressed in thymic T reg cells and that in c-rel/ mice, thymic T reg cell 
numbers are markedly reduced as a result of a T cell–intrinsic defect that is manifest 
during thymocyte development. Although c-Rel is not essential for TGF- conversion of 
peripheral CD4+CD25 T cells into CD4+Foxp3+ cells, it is required for optimal homeostatic 
expansion of peripheral T reg cells. Despite a lower number of peripheral T reg cells in  
c-rel/ mice, the residual peripheral c-rel/ T reg cells express normal levels of Foxp3, 
display a pattern of cell surface markers and gene expression similar to those of wild-type 
T reg cells, and effectively suppress effector T cell function in culture and in vivo. Collec-
tively, our results indicate that c-Rel is important for both the thymic development and 
peripheral homeostatic proliferation of T reg cells.
© 2009 Isomura et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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in number, residual c-rel/ T reg cells express normal levels of 
Foxp3 and exhibit a phenotype similar to that of normal T reg 
cells. Moreover, c-Rel appears to be dispensable for T reg cell 
immune regulatory function in culture and in vivo. Collec-
tively these findings indicate that c-Rel is a transcription factor 
that regulates both the thymic development and peripheral ho-
meostatic expansion of T reg cells.
RESULTS
Thymic and peripheral T reg cell numbers are markedly 
reduced in c-rel/ mice
Conditional deletion of ikk2 in T lineage cells, which blocks 
activation of the classical NF-B pathway, disrupts T reg cell 
intracellular signaling pathways engaged by these receptors im-
pairs nT reg cell differentiation (Liston and Rudensky, 2007). 
Although the majority of Foxp3+ T reg cells develop in the 
thymus (Fontenot et al., 2005a), TGF- is also able to pro-
mote the differentiation of mature CD4+CD25Foxp3 pe-
ripheral T cells into CD4+CD25+Foxp3+ cells that possess T 
cell suppressive properties akin to those of nT reg cells (Chen 
et al., 2003; Marie et al., 2005).
Although the Foxp3 transcription factor is essential for 
the T cell–suppressive properties of T reg cells (Fontenot et al., 
2003; Hori et al., 2003; Williams and Rudensky, 2007), 
Foxp3 itself does not appear to be a T reg cell lineage-
 determining transcription factor (Gavin et al., 2007; Lin et al., 
2007; Zheng and Rudensky, 2007). Instead, Foxp3 functions 
by maintaining a pattern of T reg cell–specific gene expres-
sion that is controlled by other transcription factors (Marson 
et al., 2007; Zheng and Rudensky, 2007; Zheng et al., 2007), 
which, by inference, must dictate the lineage determination 
of CD4+Foxp3+ T cells.
The Rel–NF-B pathway has been implicated in the 
generation of T reg cells (Siebenlist et al., 2005; Liston and 
Rudensky, 2007). The transcriptional mediators of this path-
way comprise homodimers and heterodimers of five related 
proteins (c-Rel, RelA, RelB, p50NF-B1, and p52NF-B2). 
In the absence of stimulatory signals, Rel–NF-B factors are 
retained in an inactive state within the cytosol by IB pro-
teins (Hayden and Ghosh, 2008). Signals emanating from the 
cell surface or intracellular receptors activate a multisubunit 
IB kinase (IKK) that, upon phosphorylating IB, targets it 
for proteosome-mediated degradation (Scheidereit, 2006), 
thereby promoting the nuclear translocation of Rel–NF-B 
factors. The classical arm of the NF-B pathway comprises 
the IKK2 kinase and the transcription factors NF-B1, RelA, 
and c-Rel (Gilmore, 2006), whereas the alternate NF-B 
pathway requires the IKK1 kinase to activate NF-B2 and 
RelB (Gilmore, 2006).
The alternate NF-B pathway is dispensable for T reg cell 
development (Siebenlist et al., 2005), whereas inactivation of 
IKK2 (Schmidt-Supprian et al., 2003) or the combined loss of 
NF-B1 and c-Rel (Zheng et al., 2003) markedly reduces thy-
mic and peripheral CD4+CD25+ cell numbers. Despite these 
links between the classical NF-B pathway and the generation 
of T reg cells, the specific roles of individual Rel–NF-kB tran-
scription factors in T reg cell differentiation and function re-
main to be determined. In this paper, we report that c-Rel 
is the critical NF-B transcription factor required to gen-
erate normal numbers of thymic and peripheral T reg cells. 
Consistent with c-Rel being highly expressed in thymic T reg 
cells, c-rel/ mice display diminished numbers of thymic 
CD4+Foxp3+ T cells as a result of a thymocyte-intrinsic 
 survival-independent defect in T reg cell development. Although 
c-Rel is not essential for TGF- conversion of CD4+CD25  
T cells into CD4+CD25+FoxP3+ cells in culture or in vivo, the 
reduced capacity of c-rel/ T reg cells to undergo homeostatic 
expansion may contribute to the lower numbers of peripheral 
T reg cells seen in c-rel/ mice. Despite a significant reduction 
Figure . T reg cell populations in Rel–NF-kB–deficient mice. Sin-
gle cell suspensions from the thymus, spleen, and lymph nodes of Rel–
NF-kB–deficient mice stained with antibodies for CD4, CD8, CD25, and 
Foxp3 were examined by flow cytometry. Representative dot plots from 
one of six independent experiments are presented with the percentage of 
cells in the relevant quadrants indicated. (A and B) For every experiment, 
organs from two mice of each genotype were analyzed separately.  
(A) Expression profiles of CD4 versus CD8 and Foxp3 versus CD25 (gated 
on CD4SP cells) for thymocyte populations in wt, nfkb1/, and c-rel/ 
(i) mice and irradiated recipients of wt or rela/ E14 fetal liver hemopoi-
etic progenitors (ii). (B) Expression profiles of CD4 versus CD25 and Foxp3 
versus CD25 (CD4 gated cells) for CD4 T cell populations in spleen and 
lymph nodes of wt and c-rel/ mice. (C) Percentage and numbers of T 
reg cells in the thymus, spleen, and lymph nodes of individual wt and c-
rel/ mice. Each symbol represents an individual mouse. *, P < 0.05; **, P 
< 0.02; ***, P < 0.01. The data were compiled from two independent ex-
periments. Horizontal bars represent the mean values of the data.
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 diminished numbers of T reg cells in peripheral lymphoid 
tissues, CD4+Foxp3+ populations were assessed in the spleen 
and lymph nodes (Fig. 1 B). Whereas c-rel/ CD4+CD25 
T cell numbers in both lymphoid compartments are normal 
(Pohl et al., 2002), CD4+CD25+Foxp3+ T cells are re-
duced 3-fold. Loss of c-Rel also leads to a reduction in 
CD4+CD25Foxp3+ T cells in these peripheral lymphoid 
organs. A similar reduction in peripheral CD4+Foxp3+ T 
cells is also observed in c-rel/ mice as old as 24 wk of age 
(unpublished data). These findings, summarized in Fig. 1 C, 
establish that c-Rel is required to generate normal numbers 
of thymic and peripheral CD4+Foxp3+ T cells.
The T reg cell deficit in c-rel/ mice arises in neonates
Mouse CD4+Foxp3+ T cells first arise in the thymus within 
2–3 d of birth (Fontenot et al., 2005a), and by day 5 (D5) suf-
ficient T reg cells have been generated to protect mice from 
developing autoimmune disease (Shevach, 2000; Sakaguchi, 
2004, 2005; Fontenot and Rudensky, 2005). To determine if 
the T reg cell deficit in c-rel/ mice occurs at the outset of 
T reg ontogeny or develops as mice age, CD4+CD25+ and 
CD4+Foxp3+ thymic populations were compared in wt and 
c-rel/ D2 and D5 neonates, as well as 28-d-old mice. At D2, 
the earliest time at which thymic Foxp3+ T cells are detectable 
(Fontenot et al., 2005a), the percentage of CD4+CD25+  
thymocytes (5–6% of CD4 SP cells) was similar in wt and 
c-rel/ mice (Fig. 2 A). Although the CD4+Foxp3+ popula-
tion is very low in D2 mice of both genotypes (Fig. 2 A and 
Table S1), it was found to be smaller in c-rel/ mice (2.5% 
vs. <0.02% of CD4+CD25+ thymocytes). By D5, despite an 
increase in the absolute numbers (Table S1) of CD4+ Foxp3+ 
thymocytes in both wt and c-rel/ mice, the proportion of 
development (Schmidt-Supprian et al., 2003). This finding 
prompted us to determine the roles of the individual tran-
scriptional mediators of the classical Rel–NF-kB pathway, 
namely p50NF-B1, RelA, and c-Rel, in T reg cell develop-
ment. Initially, thymic CD4+Foxp3+ populations were ex-
amined in c-rel/ and nfkb1/ mice, as well as in lethally 
irradiated Ly5.1+ C57BL/6 mice engrafted with embryonic 
day 13 (E13) rela/ fetal liver hemopoietic stem cells 
(Ly5.2+). The use of radiation chimeras is required to exam-
ine the role of RelA in T reg cell development as a result of 
the death of rela/ embryos at E15 from fetal hepatocyte 
apoptosis (Beg et al., 1995).
Total thymocyte cellularity and the relative frequencies of 
CD4CD8, CD4+CD8+, CD4+CD8, and CD4CD8+ 
thymocytes in 6–8-wk-old mice are normal in the absence 
of c-Rel, NF-B1, or RelA (Grossmann et al., 2000; Pohl 
et al., 2002). However, the proportion of CD4+CD25+Foxp3+ 
thymocytes, although normal in nfkb1/ mice and 2.5-
fold lower in rela/ chimeras, are reduced 6–7-fold in 
c-rel/ mice (Fig. 1 A). c-rel/ CD4+CD25-Foxp3+ thymo-
cyte numbers are also reduced in similar proportions (Fig. 1 A, i) 
but, interestingly, this population is slightly elevated in the 
rela/ chimeras (Fig. 1 A, ii). Given that c-Rel appeared to 
be the most important of the Rel–NF-kB transcription fac-
tors necessary for the generation of CD4+Foxp3+ thymo-
cytes, subsequent work focused on the role of c-Rel in T reg 
cell development and function.
The peripheral T reg cell population is mainly, but not 
exclusively, derived from cells generated in the thymus 
(Fontenot and Rudensky, 2005; Fontenot et al., 2005a; 
Sakaguchi, 2005; Ziegler, 2006). To ascertain if fewer 
CD4+Foxp3+ thymocytes in c-rel/ mice translate into 
Figure 2. Thymic and splenic T reg populations in wt and c-rel/ neonates. (A and B) Percentages of CD4+CD25+, CD4+CD25+Foxp3+, and 
CD4+CD25Foxp3 thymocytes (A) and splenic T cells (B) as a proportion of CD4 SP cells in 2-, 5-, and 28-d-old wt and c-rel/ mice. Each symbol represents 
an individual mouse. Data for individual mice were compiled from four independent experiments. Horizontal bars represent the mean values of the data.
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reflects a failure to generate normal numbers of these cells in 
the thymus during neonatal development.
The reduction in c-rel/ T reg cells is caused  
by a hemopoietic defect
The development of different T cell populations is dependent 
on thymocyte interactions with other hemopoietic cells, includ-
ing DCs, as well as nonhemopoietic stroma such as thymic epi-
thelial cells (Takahama, 2006). Rel–NF-kB involvement in the 
development and function of both hemopoietic (Gerondakis 
et al., 2006) and epithelial cells (Pasparakis et al., 2002; Gugasyan 
et al., 2004) prompted the generation of bone marrow chimeras 
CD4+CD25+Foxp3+ cells in the CD4 SP thymocyte popula-
tion remains four- to fivefold lower in c-rel/ mice (Fig. 2 A). 
Unlike at D2, the difference in T reg cell numbers in these 
mice at D5 was now also reflected in the relative proportion 
of CD4+CD25+ thymocytes (5 vs. 3% in wt and c-rel/ 
mice, respectively; Fig. 2 A). A similar trend was also observed 
in the CD4+CD25Foxp3+ thymocyte populations of D2 and 
D5 neonates (Fig. 2 A). CD4+Foxp3+ (both CD25+ and 
CD25) splenic T cells are also reduced in D5 c-rel/ neo-
nates (Fig. 2 B) and these trends were replicated in the D28 
thymic and spleen samples (Fig. 2 B). Together, these data in-
dicate that the deficit of CD4+Foxp3+ T cells in c-rel/ mice 
Figure 3. The c-rel/ T reg cell deficit results from a thymocyte-intrinsic defect. (A) The c-rel/ T reg cell deficit arises from a cell-autonomous 
defect. wt, c-rel/, or mixtures of equal numbers of wt (Ly5.1 and Ly5.2) or wt (Ly5.1) and c-rel/ (Ly5.2) bone marrow cells were engrafted into irradi-
ated recipients (Ly5.2+ mice) and, 8 wk later, T reg cell populations were examined in thymus, spleen, and blood. Each symbol represents an individual 
mouse. The data are representative of two independent experiments using similar numbers of mice in each experimental group. (B) The T reg cell deficit in 
c-rel/ mice is the result of a hemopoietic defect. Irradiated wt and c-rel/ mice (Ly5.2) were engrafted with wt bone marrow (Ly5.1) and, 8 wk later, 
donor-derived T reg cell (Ly5.1) numbers were determined in the thymus, spleen, and blood. Each symbol represents an individual mouse. The data are 
representative of two independent experiments using similar numbers of mice in each experimental group. Horizontal bars represent the mean values of 
the data. (C) Thymic DC-induced T reg cell differentiation in culture. wt and c-rel/ CD4+CD25 thymocytes and wt CD8Sirp+ DC cultured with IL-7 for 
5 d were stained with antibodies for CD25 and Foxp3. The data shown is representative of two independent experiments. In both experiments, there were 
duplicates for cultures using each combination of wt and c-rel/ thymocyte and DC. (D) Reduced T reg cell differentiation of c-rel/ CD4+CD8+ thymo-
cytes in culture. Equal numbers of CD4+CD8lo cells generated in culture after anti-CD3 antibody activation of wt and c-rel/ CD4+CD8+ thymocytes ex-
pressing a Bcl-2 transgene (bcl2Tg) were stained with control or Foxp3 specific antibodies. The data shown is representative of three independent 
experiments. In each experiment, the cultures for cells of each genotype were performed in triplicate.
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and Strasser, 2003) raised the possibility that a survival defect 
might account for the reduced number of c-rel/ thymic or 
peripheral T reg cells. This was assessed by introducing a bcl-2  
transgene (bcl-2Tg) under the control of the hemopoietic-
 restricted vav promoter (Ogilvy et al., 1999) onto the c-rel/ 
background. The bcl-2Tg increased overall thymocyte cellularity 
in wt and c-rel/ mice compared with nontransgenic counter-
parts (not depicted), yet bcl-2Tg expression did not correct the 
selective reduction in c-rel/ CD4+CD25+Foxp3+ thymocytes 
(Fig. 4). Although bcl-2Tg expression led to an increase in the 
proportion of CD4+CD25Foxp3+ thymocytes in both wt and 
c-rel/ mice when compared with nontransgenic counterparts 
(compare Fig. 4 and Fig. 1 A), the frequency of this Foxp3+ 
population remained lower in c-rel/bcl-2Tg compared with 
c-rel+/+bcl-2Tg mice (Fig. 4). This indicated that Bcl2 expres-
sion has a differential impact on the CD4+CD25+Foxp3+ and 
CD4+CD25+Foxp3+ thymocyte populations. An examination 
of the CD4+Foxp3+ populations in the spleen and lymph nodes 
of c-rel+/+bcl-2Tg and c-rel/bcl-2Tg mice revealed a similar 
picture to that seen in the thymus, with enforced Bcl-2 expres-
sion failing to rescue the diminished c-rel/ CD25+Foxp3+ 
to assess the contributions of the hemopoietic and stromal com-
partments to the reduction in c-rel/ T reg cells.
In irradiated wt (Ly5.1) recipients of c-rel/ bone marrow 
(Ly5.2), the percentage and absolute number (not depicted) 
of CD4+CD25+Foxp3+ thymocytes, like those in c-rel/ 
mice, were reduced compared with recipients of wt (Ly5.2) 
bone marrow (Fig. 3 A). In contrast, the CD4+CD25+Foxp3+ 
thymic population was normal in the reciprocal bone marrow 
donor/recipient combination where c-rel/ (Ly5.2) mice 
were engrafted with Ly5.1+ wt bone marrow (Fig. 3 B). Simi-
lar conclusions were made for the T reg cell population in the 
peripheral lymphoid tissues and blood of the chimeras (Fig. 3, 
A and B). These experiments indicate that the thymic and 
peripheral T reg cell deficiency in c-rel/ mice represents a 
hemopoietic rather than a stromal defect.
The defect in c-rel/ CD4 Foxp3+ thymocyte development 
is thymocyte intrinsic
Despite bone marrow chimeras establishing that the c-rel/ 
T reg cell deficit is the result of a hemopoietic defect, these 
experiments did not distinguish between defects intrinsic to 
CD4+ thymocytes and defects in other hemopoietic cells in-
volved in T reg cell differentiation. Two approaches were 
used to address this question. First, chimeras were generated 
by introducing an equal mix (1:1) of wt (Ly5.1) and c-rel/ 
(Ly5.2) bone marrow cells into irradiated wt (Ly5.2) recipi-
ents. The proportion of wt CD4+Foxp3+ cells in the thymus 
and peripheral lymphoid organs was normal, yet the c-rel/ 
CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ (not depicted) 
populations were reduced, resembling those in c-rel/ mice 
or wt recipients of c-rel/ bone marrow (Fig. 3 A).
The second approach used cell culture models of thymic T 
reg cell differentiation. In one model, CD4+CD25-Foxp3 thy-
mocytes were cultured for 5 d with thymic CD8 Sirpa+ DC, 
which preferentially converts these thymocytes into T reg cells 
(Proietto et al., 2008). In these cultures, significantly more T reg 
cells were generated from wt than c-rel/ CD4+CD25 thymo-
cytes (Fig. 3 C). In another cell culture model, T reg cells were 
generated by TCR and CD28 costimulation of CD4+CD8+ 
thymocytes (Tai et al., 2005). This method used wt and c-rel/ 
thymocytes expressing a Bcl-2 transgene to prevent the high 
levels of CD4+CD8+ thymocyte apoptosis that normally accom-
panies TCR activation (Hettmann et al., 1999). After anti-CD3 
plus anti-CD28 antibody activation, cells were cultured for an 
additional 48 h, after which CD4+CD8lo cells were stained for 
Foxp3 (Fig. 3 D). Despite TCR and CD28 stimulation generat-
ing similar frequencies of wt and c-rel/ CD4+CD8lo T cells, 
Foxp3+ cell numbers were 3-fold lower in the c-rel/ 
CD4+CD8lo population. Together, these experiments establish 
that c-rel/ thymocytes have an intrinsic defect in their capacity 
to differentiate into T reg cells.
The reduction in c-rel/ thymic T reg cells is not a result 
of impaired survival
The role of c-Rel in promoting cell survival through the induc-
tion of genes encoding Bcl-2 prosurvival proteins (Gerondakis 
Figure 4. Bcl-2 transgene expression fails to rescue the T reg cell 
deficit in c-rel/ mice. CD4+CD8 thymocytes and CD4+CD25+ spleen 
and lymph node cells from c-rel+/+bcl2Tg and c-rel/bcl2Tg mice were 
stained with antibodies for CD25 and Foxp3. Representative dot plots 
from an individual mouse of either genotype are presented with the per-
centage of cells in the relevant quadrants indicated. Two mice of each 
genotype were analyzed in each experiment and the data are from one of 
three independent experiments.
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After the addition of IL-2 during TGF-–induced T reg cell 
differentiation, the proportion of cultured wt and c-rel/ 
CD4+Foxp3+ T cells increased to between 93 and 95% 
(Fig. 6 A). Although the frequency of TGF-–generated wt and 
c-rel/ Foxp3+ cells was similar, absolute numbers of c-rel/ 
Foxp3+ cells recovered in culture were two- to threefold lower 
than for wt Foxp3+ cells, irrespective of whether IL-2 was pres-
ent (Fig. S2). This reduced number of c-rel/Foxp3+ cells re-
flects a decrease in c-rel/ CD4+ T cells recovered after TGF- 
stimulation (Fig. S2) that coincides with diminished TCR-
mediated c-rel/ T cell proliferation (Fig. S3).
population (Fig. 4). Collectively, these data show that the re-
duced number of CD4+Foxp3+ cells in c-rel/ mice is not the 
result of a defect in the Bcl-2 survival pathway.
c-Rel is up-regulated in thymic T reg cells
The reduction in c-rel/ thymic T reg cells resulting from a 
thymocyte intrinsic defect raised the issue of c-Rel expression 
during thymopoiesis and how this might relate to T reg cell 
development. This was determined by Western blot analysis 
of c-Rel expression in total cell lysates from CD4+CD8+, 
CD4CD8+, CD4+CD25, and CD4+CD25+ thymocytes 
(Fig. 5 A). Whereas c-Rel is barely detectable in CD4+CD8+ 
cells and its expression is only marginally higher in CD4-CD8+ 
and CD4+CD25 thymocytes, c-Rel levels, like those of 
Foxp3, are dramatically elevated in the CD4+CD25+ popula-
tion. RelA levels in contrast do not differ between CD4+CD25 
and CD4+CD25+ thymocytes (Fig. 5 A). Consistent with the 
protein expression data, real-time PCR confirmed that c-rel, 
but not rela, messenger RNA (mRNA) is specifically up-
 regulated in CD4+CD25+ thymocytes (Fig. 5 B). nfkb1 
mRNA levels are also somewhat elevated in CD4+CD25+ 
thymocytes compared with CD4+C25 cells. These findings, 
coupled with the phenotype in c-rel/ mice, indicated that 
high levels of c-Rel may be necessary for the maintenance of 
the T reg cell population. Surprisingly, Western blotting of 
cytosolic and nuclear fractions from wt CD4+CD25+ thymo-
cytes revealed that c-Rel could only be detected in the cytosol 
(Fig. 5 C), indicating that constitutive c-Rel activation does 
not appear to be essential for the maintenance of thymic T reg 
cells. The expected pattern of c-Rel expression in the cyto-
plasm and nucleus of resting and activated B cells (Fig. S1) 
validated the accuracy of the fractionation process used to 
 examine T reg cells.
c-Rel is required for the homeostatic proliferation  
of peripheral T reg cells
Although thymus-derived CD4+Foxp3+ T cells are the major 
source of T reg cells (Fontenot and Rudensky, 2005; Fontenot 
et al., 2005a; Sakaguchi, 2005; Ziegler, 2006), the TGF-–
 induced differentiation of CD4+CD25 T cells into T reg cells 
(Chen et al., 2003; Marie et al., 2005), coupled with T reg cell 
proliferation, collectively determines the size of the peripheral 
T reg cell population. To determine if c-Rel is necessary for 
TGF-–dependent conversion of CD4+CD25 T cells into T 
reg cells, wt and c-rel/ CD4+CD25 T cell cultures were ini-
tially subjected to TCR activation in the absence or presence of 
TGF-. Given that IL-2 enhances the generation of TGF-–
 induced T reg cells in culture by promoting T cell proliferation 
(Kretschmer et al., 2005) and TCR-mediated CD4+CD25  
T cell proliferation requires the c-Rel dependent expression of 
IL-2 (Köntgen et al., 1995; Rao et al., 2003), the influence of 
IL-2 on TGF-–induced c-rel/ T reg cell differentiation was 
also determined (Fig. 6 A).
Without TGF-, 1% of activated wt and c-rel/ cells 
were Foxp3+. In the absence of IL-2, this increased to 33% 
for cells of both genotypes in the presence of TGF- (Fig. 6 A). 
Figure 5. c-Rel is highly expressed in thymic T reg cells. (A) Western 
blot analysis of c-Rel, RelA, and Foxp3 expression in different thymocyte 
populations. Western blot analysis of total cell lysates was used to deter-
mine c-Rel and Foxp3 expression in purified wt populations of CD4CD8+, 
CD4+CD8+, CD4+CD25, and CD4+CD25+ thymocytes and RelA expression 
in wt CD4+CD25 and CD4+CD25+ thymocyte populations. ERK or actin 
expression served as loading controls. The data are representative of two 
independent experiments using different lysate samples prepared from 
thymocyte populations purified from the pooled thymi of three mice for 
each experiment. (B) c-rel, rela, and nfkb1 mRNA levels in thymocyte pop-
ulations. The levels of c-rel, rela, and nfkb1 mRNA expressed in purified 
CD4+CD25+ and CD4+CD25 thymocyte populations were determined by 
real-time PCR. The data represents duplicate PCRs performed on individual 
samples from each of four independent sets of cells. Error bars represent 
SEM. (C) c-Rel is localized in the cytoplasm of thymic T reg cells. Nuclear 
and cytoplasmic fractions from purified CD4+CD25+ thymocytes were sub-
jected to Western blotting analysis using antibodies for c-Rel, ERK, and 
histone H3. The data shown is representative of two independent experi-
ments using different preparations of nuclear and cytoplasmic lysates.
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nor population in the lymph nodes of individual mice was 
compared using paired data analysis. Although naive c-rel/ 
CD4+CD25 T cells can convert to T reg cells in vivo, the 
absolute number and percentage of c-rel/ T reg cells was 
reduced when compared with the wt population.
To determine if the impaired T reg cell proliferation ob-
served in culture also occurs in vivo, we examined the ho-
meostatic expansion of c-rel/ T reg cells under competitive 
conditions in a lymphopenic host. A 1:1 mix of wt (Ly5.1+ 
and Ly5.2+) or wt (Ly5.1+) and c-rel/ (Ly5.2+) CD4+CD25+ 
T cells was introduced into rag-1/ mice, and between 
4 and 12 wk later the number of T reg cells in lymph nodes 
from the different donors was determined. In contrast with 
The conversion of c-rel/ CD4+CD25- T cells into 
CD4+Foxp3+ cells in vivo was also examined (Curotto de 
Lafaille et al., 2004; Almeida et al., 2006). The relative ef-
ficiency with which a T reg cell population develops from 
c-rel/ CD4+CD25- cells was determined by injecting a 
1:1 ratio of wt (Ly5.1) and c-rel/ (Ly5.2) CD4+CD25 T 
cells into rag-1/ mice. 18 d later, the number (Fig. 6 B) 
and frequency (Fig. S4) of CD4+Foxp3+ cells from each do-
Figure . The roles of c-Rel in T reg cell conversion and homeo-
static expansion. (A) TGF- induced differentiation of c-rel/ T reg cells 
in culture. wt and c-rel/ splenic CD4+CD25 T cells incubated with anti-
CD3 antibodies and irradiated T cell–depleted allophycocyanin (APC) in 
the absence or presence of TGF- (with or without IL-2) for 4 d were 
stained with antibodies specific for CD25 and Foxp3. Representative dot 
plots from one of four independent experiments are presented with the 
percentage of cells in the relevant quadrants indicated. In each experi-
ment, there were triplicate cultures for each set of stimulation conditions. 
(B) T reg cell conversion in vivo. Mesenteric lymph node (MLN) cells iso-
lated from rag-1/ mice injected 18 d earlier with either a 1:1 mix of 
purified splenic CD4+CD25 wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) and c-
rel/ (Ly5.2+) T cells were stained with antibodies specific for CD4, CD8, 
CD45.1 (Ly5.1), and Foxp3. The data compares the absolute numbers of wt 
(Ly5.1+ and Ly5.2+, squares and circles, respectively) and c-rel/ (Ly5.2+, 
triangles) CD4+Foxp3+ cells detected in the mesenteric lymph nodes of 
individual mice receiving each mixture of cells. Horizontal bars represent 
the mean values of the data. Error bars represent SD. The data were ana-
lyzed using a paired Student’s t test and is representative of two indepen-
dent experiments, with a minimum of five mice in each recipient group. 
(C). c-Rel is necessary for optimal homeostatic expansion of T reg cells in 
lymphopenic mice. MLN cells isolated from rag-1/ mice injected be-
tween 4 and 8 wk earlier with either a 1:1 mix of purified wt (Ly5.1+, 
squares; Ly5.2+, circles) or wt (Ly5.1+, squares) and c-rel/ (Ly5.2+, tri-
angles) splenic CD4+CD25+ T cells were stained with antibodies specific 
for CD4, CD8, CD45.1 (Ly5.1), and Foxp3. The data shows the number of 
MLN T reg cells of each donor type in recipient mice (six per group) from 
one experiment. The data shown is representative of three independent 
experiments with five or six mice in each recipient group.
Figure . Foxp3, CD25, CTLA4, and GITR expression in thymic and 
splenic CD4+CD25+ and CD4+CD25+Foxp3+ T cells. (A and B) wt and 
c-rel/ CD4+CD25+ thymocytes (A) and splenocytes (B) were stained with 
antibodies for Foxp3, CD25, CTLA4, or GITR. Representative profiles from 
one of five independent experiments are shown for wt (line) and c-rel/ 
(dashed line) cells stained with control (filled) and test (open) antibodies. 
In each experiment, a single mouse of each genotype was used. (C) Rela-
tive mRNA levels for foxp3, cd25, ctla4, and gitr were determined by  
RT-PCR from purified populations of wt (closed) and c-rel/ (open) CD4SP, 
CD4+CD25+, and CD4+CD25 thymocytes. The data represents the mean 
value from duplicate PCRs performed on individual samples from each of 
three independent sets of cells.
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2–3-fold) in c-rel/ CD4+CD25+ thymocytes compared 
with WT CD4+CD25 thymocytes (Table I). Expression of 
a smaller number of the genes examined, namely CD127, 
CD40L, and Bcl2, was decreased in the thymic CD4+CD25+ 
population compared with CD4+CD25 cells (Table I), and, 
interestingly, expression of several of these genes were in-
creased in the absence of c-Rel (Table I) . In contrast, loss of 
c-Rel did not significantly influence gene expression patterns 
in splenic CD4+CD25+ T cells (unpublished data). Therefore, 
we conclude that c-Rel appears to have a role in modulating 
the gene expression profile of thymic CD4+CD25+ cells.
c-Rel is not required for T reg cell function in culture
To evaluate the immune suppressive properties of c-rel/ T 
reg cells, we first determined their capacity to inhibit CD4+ ef-
fector T cell proliferation in culture. Initially, suppression assays 
were performed using spleen and lymph node CD4+CD25+  
T cells isolated from wt and c-rel/ mice. In these assays, 
c-rel/ T reg cells were found to be slightly less effective at 
suppressing T cell proliferation than wt T reg cells (Fig. 8 A). 
Given that the frequency of Foxp3+ cells in the c-rel/ 
CD4+CD25+ T cell population was slightly less compared 
with wt CD4+CD25+ T cells (Fig. 7 B and Fig. S5), to deter-
mine if the reduced suppressive capacity of c-rel/ CD4+CD25+ 
splenic T cells simply reflected fewer numbers of Foxp3+ T reg 
cells in this population, we also examined the suppressive 
properties of c-rel/ T reg cells generated in culture. First, wt 
and c-rel/ CD4+CD25- T cells were transduced with retro-
viruses coexpressing gfp and murine foxp3. Greater than 96% of 
wt and c-rel/ T cells infected with the GFP-Foxp3 virus ex-
pressed Foxp3, and Western blotting confirmed that its levels 
were equivalent in both groups of cells (Fig. S5). Whereas 
T cells infected with a GFP-only control virus failed to sup-
press CD4+CD25 T cell proliferation (not depicted), both 
wt and c-rel/ GFP+Foxp3+ T cells were equally effective at 
inhibiting T cell proliferation (Fig. 8 B). wt and c-rel/ 
CD4+CD25+ T cells generated by stimulating activated 
CD4+CD25 T cells with TGF- plus IL-2 (both 97–98% 
Foxp3+; Fig. S5) were also found to be equally effective at sup-
pressing T cell proliferation (Fig. 8 C). Collectively, these data 
indicate that in culture c-Rel is dispensable for the immune 
suppressive properties of T reg cells.
c-rel/ T reg cells inhibit T cell–dependent colitis
To determine if c-rel/ T reg cells can inhibit T cell–mediated 
autoimmune disease, we used a model of T cell–dependent 
colitis induced in Rag-deficient mice after the adoptive trans-
fer of CD4+CD25CD45RBhi T cells that can be prevented 
by cotransferring T reg cells (Asseman et al., 1999). 
CD4+CD25CD45RBhi T cells (4 × 105) were injected into 
rag-1/ mice alone or with 105 wt or c-rel/ CD4+CD25+  
T cells. Mice were monitored for signs of illness (weight loss 
and diarrhea) over a 10-wk period. All sick mice and any re-
maining healthy mice were euthanized and histological analy-
sis of colon sections performed. Whereas all mice injected 
with only CD4+CD25CD45RBhi T cells developed colitis, 
control mice, which retain a similar ratio of wt Ly5.1+ and 
Ly5.2+ T reg cells to the starting populations after homeo-
static expansion, the number of c-rel/ T reg cells was always 
significantly less compared with cotransferred wt T reg cells 
(Fig. 6 C). This indicates that the capacity of c-rel/ T reg 
cells to undergo homeostatic expansion is reduced.
Phenotypic properties of c-rel/ CD4+ T reg cells
Although c-Rel is necessary for generating normal numbers 
of thymic and peripheral T reg cells, it was unclear what im-
pact the absence of c-Rel had on the phenotype of the re-
maining T reg cells. This issue was addressed by comparing 
the mRNA and protein expression of various characteristic 
T reg cell markers in wt and c-rel/ CD4+CD25+ thymocytes 
and splenic T cells (Fig. 7). Real-time PCR and intracellular 
staining established that the levels of Foxp3 expression are 
equivalent in wt and c-rel/ CD4+CD25+ thymocytes and 
splenic T cells (Fig. 7, A and C). This indicates that c-Rel does 
not control Foxp3 expression. Although CD25 and CTLA4 
protein expression is normal in c-rel/ thymic and splenic T reg 
cells, glucocorticoid-induced TNF receptor–related (GITR) 
protein levels are marginally lower on c-rel/ CD4+CD25+  
thymocytes but not c-rel/ CD4+CD25+ splenic T cells (Fig. 7, 
A and B). These data are also borne out by mRNA analyses 
(Fig. 7 C and not depicted).
Genes expressed in CD4+ T cells, including those relevant 
to CD4+Foxp3+ T reg cell function (Marson et al., 2007; 
Zheng et al., 2007) and genes known to be c-Rel targets 
(Bunting et al., 2007), were also examined by real-time PCR 
(Table I). As expected, a group of these genes were enriched 
in the thymic or splenic CD4+CD25+ population compared 
with the CD4+CD25 population (Table I). Several of these 
genes, including Il10, 41BB, CREM, MAP3K8, Irf4, Bcl2l1, 
Ox40, and Ebi3, showed a decrease in expression (generally 
Table I. Comparison of mRNA levels in CD4SPCD25+ and 
CD4SPCD25 thymocytes in WT and c-rel/ mice
Gene name Fold enrichment in 
CD4SPCD25+ compared  
with CD4SPCD25  
thymocytes
Fold change in 
CD4SPCD25+ 
thymocytes between WT 
and c-rel/ mice
I110 63 0.23
Ebi3 31.25 0.38
Tnfrsf9 (41BB) 26.6 0.46
Nt5e (CD73) 7.9 0.55
Tnfrsf4 (Ox40) 6.9 0.53
Map3k8 3.2 0.17
Crem 2.8 0.09
Bc1211 2.75 0.54
Irf4 2.25 0.33
117r (CD127) 0.31 1.8
Cd401g 0.28 3.1
Bc12 0.22 3.0
Values given for fold enrichment and fold change are means of at least two 
independent biological replicates with duplicate PCRs performed for each experiment.
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findings support a model in which the development of T reg 
cells in the thymus and maintenance of the T reg cell pheno-
type have distinct molecular requirements, with c-Rel be-
longing to that class of transcription factors whose function is 
important in regulating thymic T reg cell differentiation.
Previously, nonredundant roles for c-Rel in the T cell lin-
eage were thought to be restricted to mature T cells and involve 
functions such as proliferation, survival, and cytokine produc-
tion (Gerondakis et al., 2006). In this paper, we establish that 
c-Rel is required during thymic T reg cell development, with 
the absence of c-Rel leading to a marked reduction in both 
CD4+CD25+Foxp3+ and CD4+CD25Foxp3+ thymocytes. 
The importance of c-Rel being expressed in thymic T reg cells 
during their development, as opposed to thymic stromal cells or 
other hemopoietic cells such as DC, was confirmed using mixed 
bone marrow chimeras and cell culture models of T reg cell 
differentiation. Consistent with this conclusion, c-Rel expres-
sion is markedly elevated in thymic T reg cells compared with 
conventional CD4 or CD8SP thymocytes.
no histological evidence of colitis was observed in animals 
that had also received wt or c-rel/ splenic T reg cells (Fig. 8, 
D and E). This indicates that c-Rel is dispensable for the 
 immune suppressive function of T reg cells in this model of 
 autoimmune disease.
DISCUSSION
Little is currently known about the roles of the classical 
NF-B pathway in the development or function of T reg 
cells. In this paper, we show that among the transcription fac-
tors operating downstream of this pathway, c-Rel is the most 
important for T reg cell development. T cell–intrinsic expres-
sion of c-Rel, although necessary for generating normal num-
bers of thymic T reg cells, is not essential for TGF-–mediated 
T reg cell differentiation. Despite a need for c-Rel during nT 
reg cell development and peripheral T reg cell homeostasis, c-
rel/ T reg cells effectively suppress CD4+ effector T cell 
proliferation in culture and prevent the induction of colitis in 
rag1/ mice engrafted with CD4+CD45RBhi T cells. These 
Figure . c-rel/ T reg cells inhibit T cell proliferation in culture and suppress CD4 T cell-dependent colitis. Varying numbers of wt and  
c-rel/ T reg cells (suppressors) from various sources (see A–C) incubated in culture with a fixed number of wt splenic CD4+CD25 T cells (effectors), 
expressed as a ratio, were activated with anti-CD3 antibodies and irradiated T cell–depleted APC for 72 h. Proliferation was monitored by 3H-thymidine 
incorporation. The data shown in A–C is the SEM for four independent experiments using each different source of T reg cells. Every data point was per-
formed in triplicate for each experiment. (A) Splenic T reg cells from wt and c-rel/ mice. (B) Foxp3+ cells generated by transducing wt and c-rel/ 
CD4+CD25 splenic T cells with GFP-Foxp3 retroviruses. (C) Foxp3+ cells generated from TGF- + IL-2–treated wt and c-rel/ CD4+CD25 splenic T cells. 
rag-1/ mice injected with CD4+CD45RBhi T cells (4 × 105) in the absence or presence of wt or c-rel/ CD4+CD25+ T cells (105, >87% Foxp3+) were mon-
itored regularly for up to 10 wk. During this period, mice displaying signs of illness or weight loss were sacrificed. After 10 wk, the remaining mice were 
weighed and sacrificed. The colons were removed from all mice and processed for histology. (D) Representative hematoxylin and eosin–stained colon 
sections from rag-1/ mice receiving CD4+CD45RBhi T cells alone or with wt or c-rel/ CD4+CD25+ T cells (n = 12 mice for each cohort). Bars, 875 µM. 
(E) Histology scores for rag-1/ mice receiving CD4+CD45RBhi T cells alone or with wt or c-rel/ CD4+CD25+ T cells based on a modification of Berg  
et al. (1996). *, P < 0.02; **, P < 0.05.
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c-Rel is not required for TGF-–dependent differentia-
tion of CD4+CD25 T cells into Foxp3+ T reg cells in cul-
ture, nor is it essential for T reg cell conversion in vivo. 
Although the size of the T reg cell population that arises in a 
lymphopenic environment from c-rel/ CD4+CD25 T cells 
is reduced when compared with wt cells, it remains unclear 
whether this reflects a genuine defect in the efficiency with 
which conversion occurs in vivo or whether it is simply the 
result of the impaired proliferation of the converted T reg 
cells, which is controlled by c-Rel. So although a failure to 
produce normal T reg cell numbers in the thymus almost 
certainly accounts for some of the peripheral T reg cell deficit 
in c-rel/ mice, the reduced capacity of c-rel/ T reg cells to 
undergo normal homeostatic expansion is also likely to con-
tribute to the overall reduction in peripheral c-rel/ T reg 
cell numbers.
Despite being reduced in number, the remaining thymic 
c-rel/ T reg cells, as assessed by key T reg cell marker ex-
pression, appear relatively normal. Foxp3 mRNA and protein 
levels are unchanged, as is the expression of characteristic 
T reg cell markers such as CTLA4, CD25, CD37, and CD73. 
Similar findings were made for splenic and lymph node T reg 
cells from c-rel/ mice, plus c-rel/ T reg cells generated in 
culture either by TGF- treatment or enforced Foxp3 expres-
sion (unpublished data). Nevertheless, the expression of sev-
eral genes was found to be lower or higher (2–3-fold in 
most instances) in c-rel/ CD4+CD25+ thymocytes but not 
in peripheral T reg cells, which is consistent with the main 
role of c-Rel in the generation of thymic Foxp3+ cells. These 
differences point to c-Rel serving as a modulator of transcrip-
tion in thymic T reg cells, which is consistent with its role 
in other cell types, including CD4+CD25 effector T cells 
(Bunting et al., 2007). It remains to be determined whether 
these differences in gene expression identified to date contribute 
to the reduction in c-rel/ thymic T reg cell numbers.
Residual c-rel/ T reg cells can inhibit CD4 effector 
T cell proliferation in culture and, importantly, prevent coli-
tis in rag1/ mice engrafted with CD4+CD45RBhi T cells. 
This indicates that the immune modulatory function of the 
remaining c-rel/ T reg cells appears to be relatively normal. 
The remaining T reg cells in c-rel/ mice also appear to be 
sufficient in number and activity to control antigen-depen-
dent T cell effector responses. T reg depletion in vivo by 
anti-CD25 antibody administration increases the frequency 
of influenza virus-specific CD8 cytotoxic T cells in mice 
during the primary immune response (Haeryfar et al., 2005). 
Nevertheless, the number of influenza virus–specific CD8 ef-
fector T cells induced in the spleen and lungs of influenza vi-
rus infected c-rel/ mice is normal (Harling-McNabb et al., 
1999). Similarly, although the OVA-induced proliferation of 
OT-I TCR transgenic T cells is enhanced after T reg deple-
tion (Salem et al., 2007; Fig. S6 A), the expansion of antigen-
stimulated OT-I CD8 T cells is equivalent in wt and c-rel/ 
mice (Fig. S6 B; Mintern et al., 2002). Although these find-
ings indicate that there are sufficient T reg cells that function 
relatively normally in c-rel/ mice to prevent the development 
Current models of thymic T reg cell differentiation favor 
a multistep process controlled by TCR, costimulatory, and 
cytokine signals, each of which is required during specific 
stages of development (Liston and Rudensky, 2007). Given 
that TCR and CD28 signaling are both crucial for T reg 
cell development (Liston and Rudensky, 2007), with c-Rel 
functioning downstream of both receptors in conventional 
CD4+ T cells (Venkataraman et al., 1995; Kahn-Perlès et al., 
1997), c-Rel could conceivably control thymic T reg cell 
differentiation at a single or multiple points. Although our 
data demonstrates that a proportion of CD25+Foxp3 CD4SP 
thymocytes, a population enriched for T reg cell precursors 
(Lio and Hsieh, 2008), appears relatively normal at the onset 
of T reg cell development in c-rel/ neonates, we cannot 
rule out that the generation of the CD25+Foxp3 T reg cell 
precursor population in c-rel/ mice is not affected. Alterna-
tively, given that Foxp3+ T reg thymocytes are markedly di-
minished in 5-d-old c-rel/ neonates, c-Rel may promote 
the development of T reg cells arising from a CD25+Foxp3 
CD4SP precursor or control the expansion of T reg cells 
once differentiation is complete. Although the differentiation 
of T reg cells from a CD4+CD25+Foxp3 precursor is IL-2 
dependent (Bayer et al., 2005; Fontenot et al., 2005b) and 
c-Rel regulates il2 transcription in conventional CD4 T cells 
(Köntgen et al., 1995; Rao et al., 2003), the inability of 
mixed bone marrow chimeras to reverse the thymic c-rel/ 
T reg cell deficit indicates that it is not the result of a failure 
to express IL-2 or other soluble factors. Furthermore, the in-
ability of a Bcl-2 transgene to reverse the c-rel/ T reg cell 
deficit rules out a role for c-Rel in controlling thymic T reg 
cell survival during or after differentiation, a function served 
by c-Rel in several other cell types (Gerondakis and Strasser, 
2003; Gerondakis et al., 2006). Recent studies (Barnes et al., 
2009; Molinero et al., 2009) have demonstrated that mice 
lacking functional CARMA1, a component of the CMB 
(CARMA1–Bcl10–Malt1) TCR adaptor complex required 
for NF-B activation (Lin and Wang, 2004), also have mark-
edly reduced numbers of thymic T reg cells. Although 
CARMA1 is required for both TCR-dependent NF-B and 
JNK2 activation (Barnes et al., 2009), the finding that the 
T reg cell deficit in CARMA mutant mice, like the c-rel/ 
mice, arises from a T cell–intrinsic defect that is independent 
of Bcl-2 prosurvival signals (Barnes et al., 2009; Molinero 
et al., 2009), provides strong support for a model in which 
the TCR-dependent activation of c-Rel via CARMA1 is 
important in T reg cell development.
The intriguing finding that c-Rel is cytosolic rather than 
nuclear in thymic T reg cells lends support to the notion that 
c-Rel is required for the differentiation rather than the mainte-
nance of T reg cells. However, sustained expression of c-Rel in 
thymic and splenic (unpublished data) T reg cells points to the 
likelihood that c-Rel serves additional functions in these cells 
in response to other signals. It remains to be determined what 
types of stimuli, which could include antigen, costimulatory, 
and cytokine signals, promote the nuclear expression of c-Rel 
in T reg cells once differentiation in the thymus is complete.
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Generation and analysis of radiation bone marrow chimeras. Bone 
marrow cells (2 × 107) isolated from the femurs of wt or c-rel/ mice were in-
jected into 8-wk-old lethally irradiated (2 × 550 Rad) recipients. The different 
combinations of bone marrow chimeras were wt or c-rel/ (both Ly5.2) bone 
marrow transferred into wt (Ly5.1) mice; wt (Ly5.1) or c-rel/ (Ly5.2) bone 
marrow transferred into c-rel/ (Ly5.2) mice; and a 1:1 mix (107 cells each) of 
wt (Ly5.1) and c-rel/ (Ly5.2) bone marrow injected into wt (Ly5.1) mice. 
Reconstitution of the hemopoietic compartment with donor stem cells was 
assessed 6 wk after transplantation by examining peripheral blood collected 
from the retroorbital vein. T reg cells from the thymus and spleen of success-
fully engrafted mice were analyzed 8 wk after transplantation.
rela/ hemopoietic cell chimeras. Control (rela+/+ or rela+/) and rela/ 
thymocytes and T cells (all Ly5.2+) were generated by engrafting irradiated 
(2 × 550 Rad) wt (Ly5.1) mice with 106 E13 fetal liver hemopoietic progeni-
tors as previously described (Grossmann et al., 1999)
Isolation of thymic DC. Pooled thymuses were used for DC extraction as 
described elsewhere (O’Keeffe et al., 2005). In brief, single cell thymic suspen-
sions prepared by mechanical processing and collagenase digestion were treated 
with EDTA. Light density cells were then collected by centrifugation and 
non-DC lineage cells depleted using magnetic beads coupled to anti–rat-IgG 
after coating them with rat anti–mouse anti-CD3, anti-CD90, anti-TER119, 
anti-RB68C5, anti-CD19, anti-CD11b, and anti-F4/80. For conventional 
DC isolation, enriched preparations were stained with anti-CD11c-FITC, 
anti-CD8-PE, anti-CD45RA-APC, and anti–Sirp-biotin plus SA-PE-Cy7. 
Conventional DCs with high forward scatter and bright staining for CD11c 
were then separated into CD8+Sirp and CD8Sirp+ populations. The pu-
rity of the sorted DC was >98%.
Generation of thymic T reg cells in culture. T reg cell differentiation 
in culture was performed using two methods. The first approach involved 
coculturing different combinations of purified wt thymic CD8Sirp+ DC 
(104 cells) with CD4+CD25 (2 × 104) thymocytes from wt or c-rel/ mice 
in the presence of IL-7 for 5 d (Proietto et al., 2008). T reg cells were identi-
fied by staining with anti–CD4-Cy5, anti–CD25-FITC, and Foxp3-PE an-
tibodies. The second culture method (Tai et al., 2005) involves activating wt 
or c-rel/ CD4+CD8+ thymocytes (106) isolated from c-rel+/+bcl-2Tg and 
c-rel/bcl-2Tg mice with 10 µg/ml of plate-bound anti-CD3 and 10 µg/ml 
of anti-CD28 antibodies for 24 h, followed by an additional 48-h in culture 
without activation, after which CD4+CD8lo cells were stained for Foxp3 as 
described in this section.
Quantitative RT-PCR. Total RNA was extracted from sorted thymic and 
splenic CD4+, CD4+CD25+, and CD4+CD25 T cells using TRI reagent 
(Sigma-Aldrich) according to the manufacturer’s specifications. Total RNA 
was DNase treated in 20 mM Tris, pH 8.3, 50 mM KCl, and 2 mM MgCl2 
using 1 U RNase-free DNase I (Roche) per 1 µg of total RNA at 37°C for 
30 min, followed by heat inactivation at 75°C for 5 min. 0.2–1 µg DNase-
treated total RNA was reverse transcribed using the first-strand complementary 
DNA (cDNA) synthesis system (OriGene) according to the manufacturer’s in-
structions. Quantitative real-time PCR was performed using an ABI PRISM 
7500 or 7900HT sequence detection system (Applied Biosystems). Reactions 
were performed in MicroAmp Optical 96-well or 384-well reaction plates (Ap-
plied Biosystems) in a final volume of 20 or 10 µl, respectively, containing 
SYBR Green Master Mix (Applied Biosystems), 300 nM of forward and reverse 
primers, and 1/10-diluted cDNA, according to the manufacturer’s guidelines 
(Applied Biosystems). To normalize for experimental variation in cDNA syn-
thesis and RNA input, PCRs for ubiquitin-conjugating enzyme (UBC) E2D 2 
were conducted in parallel. The primer pairs used are listed in Table S2.
Western blotting. Equal amounts of total cellular protein from FACS-
 purified populations of thymocytes (CD4+CD8+, CD8+CD4, CD4+CD25, 
and CD4+CD25+) and splenic T cells (CD4+CD25 and CD4+CD25+) 
were loaded on 10% Novex gels (Invitrogen) and then subjected to 
of autoimmune disease and limit effector T cell activity dur-
ing certain immune responses, it remains a possibility that 
defects in other c-rel/ cells, such as effector T cells or DC, 
also contribute to the failure of autoimmune disease to de-
velop in these mice.
Collectively, the data presented in this paper indicates 
that c-Rel belongs to a class of transcription factors required 
for thymic T reg cell differentiation and peripheral homeo-
static proliferation but not the immune function of mature 
T reg cells. However, this needs to be confirmed by examin-
ing the function of c-rel/ T reg cells across the gamut of 
immune responses controlled by T reg cells.
MATERIALS AND METHODS
Mice. C57BL/6 mice (Ly5.1 and Ly5.2) were used as wt controls. c-rel/ 
(Köntgen et al., 1995), nfkb1/(Sha et al., 1995), rela+/(Beg et al., 1995), 
rag-1/, vav-bcl-2 transgenic (bcl-2Tg; Ogilvy et al., 1999), and c-rel/bcl-2Tg 
(Grumont et al., 2002) mice are all on a C57BL/6 background (Ly5.2, N: 
9–12 backcrossed generations; rela+/, 35 backcrossed generations). OT-I 
(C57BL/6) mice were on a Ly5.1 background. With the exception of E14 
rela+/+, rela+/, and rela/ embryos used for fetal liver hemopoietic cell en-
graftment of irradiated recipients and neonates used for ontogeny studies, all 
other experimental mice were used between 7 and 10 wk of age. Genotypes 
of embryos from rela+/ intercrosses were determined by PCR. All animal 
protocols were approved by the Research Directorate of Melbourne Health, 
the Animal Ethics Committee of the Australian National University, and the 
University of Queensland Animal Ethics Committee.
Reagents. The following antibodies were used: biotin, PE, APC, or Cy5-
conjugated anti-CD4 (GK1.5), anti–mouse biotin-conjugated anti-CD3 
(145-2C11), FITC-conjugated anti-CD25 (PC61.1), PE-conjugated anti-
GITR (DTA-1), PE-conjugated anti–CTLA-4 (UC10-4B9), and PE- or 
APC-conjugated anti–mouse Foxp3 (FJK-16S). Streptavidin-conjugated PE-
Cy5 and PE-conjugated CD45RB (C363.16A) were purchased from eBiosci-
ence. Streptavidin-peridinin chlorophyll-a protein (SA-PerCP) was obtained 
from BD. PE-conjugated CD25 (7D4) anti-biotin microbeads were obtained 
from Miltenyi Biotec. TGF- and recombinant murine IL-2 were purchased 
from R&D Systems and PeproTech, respectively. Dulbecco’s Modified Eagle 
Medium supplemented with 10% FBS was used for cell culture.
Isolation of CD4+CD25+ and CD4+CD25 T cells. CD25+ and CD25 
CD4SP thymocytes were purified by first using an enrichment step that 
 involved depleting anti–CD8-biotin–labeled CD8+ cells with anti-biotin 
microbeads (Miltenyi Biotec), after which the unbound flow-through frac-
tion stained with anti–CD4-PE, anti–CD8-biotin plus SA-PE-Cy5, and 
anti–CD25-FITC was sorted for CD4+CD25+ and CD4+CD25 thymo-
cytes using a MoFlo (Dako). T reg cells in spleen and lymph nodes were iso-
lated from wt and c-rel/ mice by preenriching cell suspensions stained with 
biotinylated anti-CD4 using anti-biotin magnetic beads (Miltenyi Biotec), 
followed by staining with anti–CD4-PE and anti–CD25-FITC and sorting 
for CD4+CD25+ and CD4+CD25 T cells. The purity of sorted CD4+CD25+ 
T cells was typically >96%.
Flow cytometric analysis. T cells in single cell suspensions of thymus, 
spleen, and lymph nodes prepared from wt and c-rel/ neonates (D2 and D5) 
or adult mice were stained with anti–CD4-APC and anti–CD25-FITC anti-
bodies. Thymocytes were also stained with biotinylated anti-CD8 antibodies 
and SA-PerCP. Intracellular Foxp3 stains were then performed using PE-
 conjugated anti-Foxp3 antibodies (eBioscience). In some experiments, intra-
cellular staining with anti–CTLA-4–PE antibodies was performed after surface 
staining cells for CD4, CD25, CD8, GITR, and Foxp3 (APC-conjugated 
Foxp3 antibodies). Stained cells were analyzed using a FACSCalibur (BD) or 
LSR (BD), and the data was analyzed using CellQuest Pro software (BD).
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In vivo suppression of experimentally induced colitis. The induction 
of experimental colitis was performed as previously described (Asseman 
et al., 1999). In brief, 4 × 105 wt CD4+CD45RBhi cells were delivered by 
intravenous injection (200 µl) into rag-1/ mice with or without 105 
CD4+CD25+ splenic T cells isolated from wt or c-rel/ mice. All animals 
were sacrificed 10 wk after the transfer of cells, with those mice that lost 
>10% of their initial body weight or were ill sacrificed beforehand. Colons 
were fixed with 10% formalin solution and stained with hematoxylin and 
eosin. Histological scoring was done in a blind fashion according to the coli-
tis severity index (epithelial hyperplasia, 0–3; cellular infiltrate, 0–3; cryptic 
abscess, 0–1) as previously described (Berg et al., 1996).
Online supplemental material. Fig. S1 shows c-Rel expression in nuclear 
and cytoplasmic fractions of resting and activated B cells. Fig. S2 shows cul-
tured CD4+ and T reg cell numbers after TGF- (with or without IL-2 
treatment). Fig. S3 shows that TCR-activated c-rel/ T cells demonstrate 
diminished proliferation after TGF- treatment. Fig. S4 shows T reg cell 
conversion in vivo. Fig. S5 shows Foxp3 expression in populations of puri-
fied peripheral nT reg cells and converted CD4+CD25 T cells. Fig. S6 
shows T reg cell control of antigen-specific effector T cell proliferation 
in c-rel/ mice. Table S1 shows the numbers of CD4+CD25+, 
CD4+CD25+Foxp3+, and CD4+CD25Foxp3+ cells in the thymus and 
spleen of 2-, 5-, and 28-d-old wt and c-rel/ mice. Table S2 shows se-
quences of the primers used for determining quantitative real-time PCR 
analysis of gene expression in wt and c-rel/ CD4+CD25 and CD4+CD25+ 
thymocytes and splenic T cells. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20091411/DC1.
The authors thank J. Adams for the Bcl-2 transgenic mice, Lina Ma for expert technical 
assistance, and Drs. Kristine Hardy and Stephen Daley for useful discussions.
This work was supported by a Program grant from the Leukemia and 
Lymphoma Society (SCOR grant 7015) and grants from the National Health and 
Medical Research Council of Australia (Program 257502 and Project 543141).
The authors have no conflicting financial interests.
Submitted: 29 June 2009
Accepted: 30 October 2009
REFERENCES
Almeida, A.R., B. Zaragoza, and A.A. Freitas. 2006. Competition 
controls the rate of transition between the peripheral pools of 
CD4+CD25- and CD4+CD25+ T cells. Int. Immunol. 18:1607–1613. 
doi:10.1093/intimm/dxl093
Asseman, C., S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie. 
1999. An essential role for interleukin 10 in the function of regulatory 
T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995–1004. 
doi:10.1084/jem.190.7.995
Banerjee, A., R. Gugasyan, M. McMahon, and S. Gerondakis. 2006. 
Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-
regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA. 
103:3274–3279. doi:10.1073/pnas.0511113103
Barnes, M.J., P. Krebs, N. Harris, C. Eidenschenk, R. Gonzalez-Quintial, 
C.N. Arnold, K. Crozat, S. Sovath, E.M. Moresco, A.N. Theofilopoulos, 
et al. 2009. Commitment to the regulatory T cell lineage requires 
CARMA1 in the thymus but not in the periphery. PLoS Biol. 7:e51. 
doi:10.1371/journal.pbio.1000051
Bayer, A.L., A. Yu, D. Adeegbe, and T.R. Malek. 2005. Essential role for 
interleukin-2 for CD4+CD25+ T regulatory cell development during the 
neonatal period. J. Exp. Med. 201:769–777. doi:10.1084/jem.20041179
Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. 
Embryonic lethality and liver degeneration in mice lacking the RelA 
 component of NF-kappa B. Nature. 376:167–170. doi:10.1038/376167a0
Bensinger, S.J., A. Bandeira, M.S. Jordan, A.J. Caton, and T.M. Laufer. 
2001. Major histocompatibility complex class II–positive cortical epi-
thelium mediates the selection of CD4+25+ immunoregulatory T cells. 
J. Exp. Med. 194:427–438. doi:10.1084/jem.194.4.427
Berg, D.J., N. Davidson, R. Kühn, W. Müller, S. Menon, G. Holland, L. 
Thompson-Snipes, M.W. Leach, and D. Rennick. 1996. Enterocolitis 
 electrophoresis and Western blotting, performed as previously described 
(Banerjee et al., 2006) using RelA and c-Rel–specific antisera (Grumont and 
Gerondakis, 1994) or anti-Foxp3 antibodies. Blots were stripped and re-
probed with anti–-actin antibodies. Western blots on nuclear and cytoplas-
mic extracts, prepared as previously described (Grumont and Gerondakis, 
1994), were conducted as described earlier in this section and probed with 
antibodies to c-Rel, after which the blots were stripped and reprobed with 
anti-ERK (Santa Cruz Biotechnology, Inc.) or histone H3–specific antibod-
ies (Santa Cruz Biotechnology, Inc.).
TGF-–induced T reg cell differentiation in culture. Purified wt or 
c-rel/ CD4+CD25- splenic T cells (2 × 105) were cultured with 1 µg/ml of 
plate bound anti-CD3 antibody plus 2 × 106 irradiated T cell–depleted sple-
nocytes in the presence or absence of 2 ng/ml of recombinant human TGF- 
(R&D Systems) for 4 d. Cells were then harvested and T reg cells quantified 
by staining for Foxp3 expression. The effect of exogenous IL-2 on TGF-–
dependent T reg cell conversion was determined by adding 50 U/ml of 
 recombinant murine IL-2 (PeproTech) on D0 and D2 of the 4-d incubation. 
To assess the proliferation of TGF-–converted cells, 5 × 104 CD4+CD25 
T cells were cultured with anti-CD3 antibodies, 5 × 105 irradiated T cell–
 depleted splenocytes, and IL-2 in the presence or absence of TGF- for 3 d 
and cultures pulsed with 1 µCi of [3H] thymidine for the final 8 h of culture. 
Incorporated radioactivity was measured by scintillation counting.
T reg cell conversion in vivo. CD4+CD25 splenic T cells (>96% pu-
rity) isolated by flow cytometry from wt (C57BL/6, Ly5.1+, and Ly5.2+) and 
c-rel/ (Ly5.2+) mice were mixed at a 1:1 ratio, and 5 × 104 cells from mix-
tures of either wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) and c-rel/ (Ly5.2+) 
CD4+CD25 T cells were injected intravenously into rag-1/ mice. 18 d 
later, cell suspensions from the spleen and mesenteric lymph nodes of indi-
vidual mice were stained with anti–CD4-APC, anti–CD8-PerCP, anti–
CD45.1-PE, and either anti–CD25-FITC or anti–FoxP3-FITC. Stained 
cells were analyzed using a FACSCalibur and the data analyzed using Flow 
Jo software (Tree Star, Inc.).
T reg cell homeostatic proliferation. CD4+CD25+ splenic T cells (>90% 
Foxp3+) purified by flow cytometry from wt (C57BL/6, Ly5.1+ and Ly5.2+) 
and c-rel/ (Ly5.2+) mice were mixed in equal numbers (1:1 ratio) and 
5 × 104 cells from mixtures either wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) 
and c-rel/(Ly5.2+) CD4+CD25+ T cells were injected intravenously into 
rag-1/ mice. Between 4 and 8 wk later, cell suspensions from the spleens and 
mesenteric lymph nodes of individual mice were stained with anti–CD4-PerCP, 
anti–CD8-PE, anti–CD45.1-APC, and anti–FoxP3-FITC antibodies. Stained 
cells were analyzed using a FACSCalibur and the data analyzed using Flow 
Jo software.
Infecting T cells with Foxp3-expressing retroviruses. A full-length 
cDNA clone encoding mouse Foxp3 (provided by S. Barry, Child Health 
Research Institute, Adelaide, Australia) was inserted into the pMY-EGFP 
retroviral vector (Grumont et al., 2004), and stocks of control (MY-EGFP) 
or MY-EGFP/Foxp3 virus were generated by transfecting Phoenix cells. 
Purified CD4+CD25 T cells activated in culture with anti-CD3 antibodies 
plus IL-2 (50 U/ml) were infected with MY-EGFP or MY-EGFP/Foxp3 
virus using a spin infection procedure (Grumont et al., 2004). After two 
rounds of infection, 20–30% of cultured cells were GFP positive.
In vitro suppression assay. Purified wt CD4+CD25 T cells (2.5 × 104) 
together with varying ratios of wt or c-rel/ splenic CD4+CD25+ T cells 
were activated with 1 µg/ml anti-CD3 mAb (145-2C11) in the presence of 
105 irradiated (3,000 Rad) T cell–depleted wt splenocytes in 96-well round 
bottom plates for 72 h. These assays were also performed using either TGF-–
converted T reg cells or CD4+CD25+ T cells generated by infecting wt or 
c-rel/ CD4+CD25 T cells with a retrovirus expression Foxp3. All cultures 
were pulsed with 1 µCi of 3H-thymidine for the final 8 h of incubation and 
then analyzed by scintillation counting.
 o
n
 D
ecem
ber 10, 2009 
jem.rupress.org
D
ow
nloaded from
 
 Published December 7, 2009
JEM 
Article
3 of 4
induced by direct priming and cross-priming and moderate immuno-
dominance disparities. J. Immunol. 174:3344–3351.
Harling-McNabb, L., G. Deliyannis, D.C. Jackson, S. Gerondakis, G. 
Grigoriadis, and L.E. Brown. 1999. Mice lacking the transcription factor 
subunit Rel can clear an influenza infection and have functional anti-
viral cytotoxic T cells but do not develop an optimal antibody response. 
Int. Immunol. 11:1431–1439. doi:10.1093/intimm/11.9.1431
Hayden, M.S., and S. Ghosh. 2008. Shared principles in NF-kappaB signal-
ing. Cell. 132:344–362. doi:10.1016/j.cell.2008.01.020
Hettmann, T., J. DiDonato, M. Karin, and J.M. Leiden. 1999. An essen-
tial role for nuclear factor B in promoting double positive thymocyte 
apoptosis. J. Exp. Med. 189:145–158. doi:10.1084/jem.189.1.145
Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell 
development by the transcription factor Foxp3. Science. 299:1057–1061. 
doi:10.1126/science.1079490
Kahn-Perlès, B., C. Lipcey, P. Lécine, D. Olive, and J. Imbert. 1997. 
Temporal and subunit-specific modulations of the Rel/NF-kappaB 
transcription factors through CD28 costimulation. J. Biol. Chem. 
272:21774–21783. doi:10.1074/jbc.272.35.21774
Köntgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and 
S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit de-
fects in lymphocyte proliferation, humoral immunity, and interleukin-2 
expression. Genes Dev. 9:1965–1977. doi:10.1101/gad.9.16.1965
Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, 
and H. von Boehmer. 2005. Inducing and expanding regulatory T 
cell populations by foreign antigen. Nat. Immunol. 6:1219–1227. 
doi:10.1038/ni1265
Lin, X., and D. Wang. 2004. The roles of CARMA1, Bcl10, and 
MALT1 in antigen receptor signaling. Semin. Immunol. 16:429–435. 
doi:10.1016/j.smim.2004.08.022
Lin, W., D. Haribhai, L.M. Relland, N. Truong, M.R. Carlson, C.B. 
Williams, and T.A. Chatila. 2007. Regulatory T cell develop-
ment in the absence of functional Foxp3. Nat. Immunol. 8:359–368. 
doi:10.1038/ni1445
Lio, C.-W.J., and C.-S. Hsieh. 2008. A two-step process for thymic 
regulatory T cell development. Immunity. 28:100–111. doi:10.1016/ 
j.immuni.2007.11.021
Liston, A., and A.Y. Rudensky. 2007. Thymic development and peripheral 
homeostasis of regulatory T cells. Curr. Opin. Immunol. 19:176–185. 
doi:10.1016/j.coi.2007.02.005
Marie, J.C., J.J. Letterio, M. Gavin, and A.Y. Rudensky. 2005. TGF-1 main-
tains suppressor function and Foxp3 expression in CD4+CD25+ regula-
tory T cells. J. Exp. Med. 201:1061–1067. doi:10.1084/jem.20042276
Marson, A., K. Kretschmer, G.M. Frampton, E.S. Jacobsen, J.K. Polansky, 
K.D. MacIsaac, S.S. Levine, E. Fraenkel, H. von Boehmer, and R.A. 
Young. 2007. Foxp3 occupancy and regulation of key target genes dur-
ing T-cell stimulation. Nature. 445:931–935. doi:10.1038/nature05478
Mintern, J.D., G. Belz, S. Gerondakis, F.R. Carbone, and W.R. Heath. 
2002. The cross-priming APC requires a Rel-dependent signal to in-
duce CTL. J. Immunol. 168:3283–3287.
Molinero, L.L., J. Yang, T. Gajewski, C. Abraham, M.A. Farrar, and M.-L. 
Alegre. 2009. CARMA1 controls an early checkpoint in the thymic 
development of FoxP3+ regulatory T cells. J. Immunol. 182:6736–6743. 
doi:10.4049/jimmunol.0900498
O’Keeffe, M., R.J. Grumont, H. Hochrein, M. Fuchsberger, R. Gugasyan, 
D. Vremec, K. Shortman, and S. Gerondakis. 2005. Distinct roles for the 
NF-kappaB1 and c-Rel transcription factors in the differentiation and 
 survival of plasmacytoid and conventional dendritic cells activated by 
TLR-9 signals. Blood. 106:3457–3464. doi:10.1182/blood-2004-12-4965
Ogilvy, S., D. Metcalf, C.G. Print, M.L. Bath, A.W. Harris, and J.M. 
Adams. 1999. Constitutive Bcl-2 expression throughout the hema-
topoietic compartment affects multiple lineages and enhances pro-
genitor cell survival. Proc. Natl. Acad. Sci. USA. 96:14943–14948. 
doi:10.1073/pnas.96.26.14943
Pasparakis, M., G. Courtois, M. Hafner, M. Schmidt-Supprian, A. Nenci, A. 
Toksoy, M. Krampert, M. Goebeler, R. Gillitzer, A. Israel, et al. 2002. 
TNF-mediated inflammatory skin disease in mice with epidermis-specific 
deletion of IKK2. Nature. 417:861–866. doi:10.1038/nature00820
and colon cancer in interleukin-10-deficient mice are associated with 
aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. 
Invest. 98:1010–1020. doi:10.1172/JCI118861
Bunting, K., S. Rao, K. Hardy, D. Woltring, G.S. Denyer, J. Wang, S. 
Gerondakis, and M.F. Shannon. 2007. Genome-wide analysis of gene 
expression in T cells to identify targets of the NF-kappa B transcription 
factor c-Rel. J. Immunol. 178:7097–7109.
Caton, A.J., C. Cozzo, J. Larkin III, M.A. Lerman, A. Boesteanu, and M.S. 
Jordan. 2004. CD4(+) CD25(+) regulatory T cell selection. Ann. N. Y. 
Acad. Sci. 1029:101–114. doi:10.1196/annals.1309.028
Chen, W., W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and 
S.M. Wahl. 2003. Conversion of peripheral CD4+CD25- naive T cells to 
CD4+CD25+ regulatory T cells by TGF- induction of transcription fac-
tor Foxp3. J. Exp. Med. 198:1875–1886. doi:10.1084/jem.20030152
Curotto de Lafaille, M.A., A.C. Lino, N. Kutchukhidze, and J.J. Lafaille. 
2004. CD25- T cells generate CD25+Foxp3+ regulatory T cells by 
peripheral expansion. J. Immunol. 173:7259–7268.
Fontenot, J.D., and A.Y. Rudensky. 2005. A well adapted regulatory con-
trivance: regulatory T cell development and the forkhead family tran-
scription factor Foxp3. Nat. Immunol. 6:331–337. doi:10.1038/ni1179
Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs 
the development and function of CD4+CD25+ regulatory T cells. Nat. 
Immunol. 4:330–336. doi:10.1038/ni904
Fontenot, J.D., J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005a. 
Developmental regulation of Foxp3 expression during ontogeny.  
J. Exp. Med. 202:901–906. doi:10.1084/jem.20050784
Fontenot, J.D., J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky. 2005b. 
A function for interleukin 2 in Foxp3-expressing regulatory T cells. 
Nat. Immunol. 6:1142–1151. doi:10.1038/ni1263
Gavin, M.A., J.P. Rasmussen, J.D. Fontenot, V. Vasta, V.C. Manganiello, 
J.A. Beavo, and A.Y. Rudensky. 2007. Foxp3-dependent programme of 
regulatory T-cell differentiation. Nature. 445:771–775. doi:10.1038/ 
nature05543
Gerondakis, S., and A. Strasser. 2003. The role of Rel/NF-kappaB tran-
scription factors in B lymphocyte survival. Semin. Immunol. 15:159–166. 
doi:10.1016/S1044-5323(03)00036-8
Gerondakis, S., R. Grumont, R. Gugasyan, L. Wong, I. Isomura, W. Ho, 
and A. Banerjee. 2006. Unravelling the complexities of the NF-kappaB 
signalling pathway using mouse knockout and transgenic models. 
Oncogene. 25:6781–6799. doi:10.1038/sj.onc.1209944
Gilmore, T.D. 2006. Introduction to NF-kappaB: players, pathways, per-
spectives. Oncogene. 25:6680–6684. doi:10.1038/sj.onc.1209954
Grossmann, M., D. Metcalf, J. Merryfull, A.A. Beg, D. Baltimore, and S. 
Gerondakis. 1999. The combined absence of the transcription factors 
Rel and RelA leads to multiple hemopoietic cell defects. Proc. Natl. 
Acad. Sci. USA. 96:11848–11853. doi:10.1073/pnas.96.21.11848
Grossmann, M., L.A. O’Reilly, R. Gugasyan, A. Strasser, J.M. Adams, and 
S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA re-
quired during B-cell maturation involve the regulation of Bcl-2 expres-
sion. EMBO J. 19:6351–6360. doi:10.1093/emboj/19.23.6351
Grumont, R.J., and S. Gerondakis. 1994. The subunit composition of 
NF-kappa B complexes changes during B-cell development. Cell Growth 
Differ. 5:1321–1331.
Grumont, R.J., A. Strasser, and S. Gerondakis. 2002. B cell growth is con-
trolled by phosphatidylinositol 3-kinase-dependent induction of Rel/
NF-kappaB regulated c-myc transcription. Mol. Cell. 10:1283–1294. 
doi:10.1016/S1097-2765(02)00779-7
Grumont, R., P. Lock, M. Mollinari, F.M. Shannon, A. Moore, and S. 
Gerondakis. 2004. The mitogen-induced increase in T cell size involves 
PKC and NFAT activation of Rel/NF-kappaB-dependent c-myc ex-
pression. Immunity. 21:19–30. doi:10.1016/j.immuni.2004.06.004
Gugasyan, R., A. Voss, G. Varigos, T. Thomas, R.J. Grumont, P. Kaur, G. 
Grigoriadis, and S. Gerondakis. 2004. The transcription factors c-rel and 
RelA control epidermal development and homeostasis in embryonic 
and adult skin via distinct mechanisms. Mol. Cell. Biol. 24:5733–5745. 
doi:10.1128/MCB.24.13.5733-5745.2004
Haeryfar, S.M.M., R.J. DiPaolo, D.C. Tscharke, J.R. Bennink, and J.W. 
Yewdell. 2005. Regulatory T cells suppress CD8+ T cell responses 
 o
n
 D
ecem
ber 10, 2009 
jem.rupress.org
D
ow
nloaded from
 
 Published December 7, 2009
4 of 4 NF-B and T reg cell development | Isomura et al.
Pohl, T., R. Gugasyan, R.J. Grumont, A. Strasser, D. Metcalf, D. Tarlinton, 
W. Sha, D. Baltimore, and S. Gerondakis. 2002. The combined ab-
sence of NF-kappa B1 and c-Rel reveals that overlapping roles for these 
transcription factors in the B cell lineage are restricted to the activation 
and function of mature cells. Proc. Natl. Acad. Sci. USA. 99:4514–4519. 
doi:10.1073/pnas.072071599
Proietto, A.I., S. van Dommelen, P. Zhou, A. Rizzitelli, A. D’Amico, R.J. 
Steptoe, S.H. Naik, M.H. Lahoud, Y. Liu, P. Zheng, et al. 2008. Dendritic 
cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. 
Acad. Sci. USA. 105:19869–19874. doi:10.1073/pnas.0810268105
Rao, S., S. Gerondakis, D. Woltring, and M.F. Shannon. 2003. c-Rel is 
required for chromatin remodeling across the IL-2 gene promoter.  
J. Immunol. 170:3724–3731.
Robey, E., and B.J. Fowlkes. 1994. Selective events in T cell devel-
opment. Annu. Rev. Immunol. 12:675–705. doi:10.1146/annurev 
.iy.12.040194.003331
Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immuno-
logic self-tolerance and negative control of immune responses. 
Annu. Rev. Immunol. 22:531–562. doi:10.1146/annurev.immunol.21 
.120601.141122
Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ reg-
ulatory T cells in immunological tolerance to self and non-self. Nat. 
Immunol. 6:345–352. doi:10.1038/ni1178
Salem, M.L., A.N. Kadima, S.A. El-Naggar, M.P. Rubinstein, Y. Chen, 
W.E. Gillanders, and D.J. Cole. 2007. Defining the ability of cyclo-
phosphamide preconditioning to enhance the antigen-specific CD8+ 
T-cell response to peptide vaccination: creation of a beneficial host mi-
croenvironment involving type I IFNs and myeloid cells. J. Immunother. 
30:40–53. doi:10.1097/01.cji.0000211311.28739.e3
Sansom, D.M., and L.S. Walker. 2006. The role of CD28 and cytotoxic 
T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. 
Immunol. Rev. 212:131–148. doi:10.1111/j.0105-2896.2006.00419.x
Scheidereit, C. 2006. IkappaB kinase complexes: gateways to NF-
kappaB activation and transcription. Oncogene. 25:6685–6705. 
doi:10.1038/sj.onc.1209934
Schmidt-Supprian, M., G. Courtois, J. Tian, A.J. Coyle, A. Israël, 
K. Rajewsky, and M. Pasparakis. 2003. Mature T cells depend 
on signaling through the IKK complex. Immunity. 19:377–389. 
doi:10.1016/S1074-7613(03)00237-1
Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted dis-
ruption of the p50 subunit of NF-kappa B leads to multifocal defects in im-
mune responses. Cell. 80:321–330. doi:10.1016/0092-8674(95)90415-8
Shevach, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. 
Immunol. 18:423–449. doi:10.1146/annurev.immunol.18.1.423
Siebenlist, U., K. Brown, and E. Claudio. 2005. Control of lymphocyte 
development by nuclear factor-kappaB. Nat. Rev. Immunol. 5:435–445. 
doi:10.1038/nri1629
Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimula-
tion of developing thymocytes induces Foxp3 expression and regula-
tory T cell differentiation independently of interleukin 2. Nat. Immunol. 
6:152–162. doi:10.1038/ni1160
Takahama, Y. 2006. Journey through the thymus: stromal guides for T-cell devel-
opment and selection. Nat. Rev. Immunol. 6:127–135. doi:10.1038/nri1781
Tang, Q., K.J. Henriksen, E.K. Boden, A.J. Tooley, J. Ye, S.K. Subudhi, 
X.X. Zheng, T.B. Strom, and J.A. Bluestone. 2003. Cutting edge: 
CD28 controls peripheral homeostasis of CD4+CD25+ regulatory 
T cells. J. Immunol. 171:3348–3352.
Venkataraman, L., S.J. Burakoff, and R. Sen. 1995. FK506 inhibits antigen 
receptor–mediated induction of c-rel in B and T lymphoid cells. J. Exp. 
Med. 181:1091–1099. doi:10.1084/jem.181.3.1091
Williams, L.M., and A.Y. Rudensky. 2007. Maintenance of the Foxp3-
 dependent developmental program in mature regulatory T cells requires con-
tinued expression of Foxp3. Nat. Immunol. 8:277–284. doi:10.1038/ni1437
Zheng, Y., and A.Y. Rudensky. 2007. Foxp3 in control of the regulatory 
T cell lineage. Nat. Immunol. 8:457–462. doi:10.1038/ni1455
Zheng, Y., M. Vig, J. Lyons, L. Van Parijs, and A.A. Beg. 2003. Combined 
deficiency of p50 and cRel in CD4+ T cells reveals an essential require-
ment for nuclear factor B in regulating mature T cell survival and in 
vivo function. J. Exp. Med. 197:861–874. doi:10.1084/jem.20021610
Zheng, Y., S.Z. Josefowicz, A. Kas, T.T. Chu, M.A. Gavin, and A.Y. Rudensky. 
2007. Genome-wide analysis of Foxp3 target genes in developing and ma-
ture regulatory T cells. Nature. 445:936–940. doi:10.1038/nature05563
Ziegler, S.F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209–
226. doi:10.1146/annurev.immunol.24.021605.090547
 o
n
 D
ecem
ber 10, 2009 
jem.rupress.org
D
ow
nloaded from
 
 Published December 7, 2009
JEM
T
h
e
 J
o
u
r
n
a
l 
o
f 
E
x
p
e
r
im
e
n
t
a
l 
M
e
d
ic
in
e
S1
SUPPLEMENTAL MATERIAL
Isomura et al., http://www.jem.org/cgi/content/full/jem.20091411/DC1
Figure S1. c-Rel expression in nuclear and cytoplasmic fractions of resting and activated B cells.Cytoplasmicandnuclearfractionsfrom
equivalentnumbers(3×106)ofpurifiedrestingoranti-IgM(25µg/ml)–activated(60min)BcellculturesweresubjectedtoWesternblotanalysisand
probedwithc-Rel–specificantibodiesasdescribedinMaterialsandmethods.c-Rellevelsinwholecellextracts(2×106)ofuntreatedandactivatedB
cellsfromthesecultureisalsoshown.Thedataarerepresentativeoftwoindependentexperiments.
Figure S2. Cultured CD4+ and T reg cell numbers after TGF- (with or without IL-2) treatment.4dafterstimulatingwtorc-rel/CD4+CD25
Tcellswithanti-CD3antibodiesandirradiatedTcell–depletedAPCintheabsenceorpresenceofTGF-(withorwithoutIL-2)totalnumbersofCD4+T
cellsandTregcells(Foxp3+)werequantifiedbyflowcytometry.Thedatarepresentsthestandarderrorofthemeanforfourindependentexperiments.In
eachindependentexperiment,therewerethreereplicateculturesofwtandc-rel/cellsforeverytypeofstimulation.
Figure S3. TCR-activated c-rel/ T cells demonstrate diminished proliferation after TGF- treatment.wtorc-rel/CD4+CD25Tcellswere
stimulatedfor4dinculturewithanti-CD3antibodiesandirradiatedTcell–depletedAPCintheabsenceorpresenceofTGF-(withorwithoutIL-2).Cul-
tureswerepulsedwith1µCi3H-thymidineforthefinal8hofculture,afterwhichcellswereharvestedandincorporatedradioactivethymidinewasde-
termined.Thedatarepresentsthestandarderrorofthemeanforfourindependentexperiments.Ineachindependentexperiment,therewerethree
replicateculturesofwtandc-rel/cellsforeverytypeofstimulation.
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Figure S4. T reg cell conversion in vivo.Mesentericlymphnodecellsisolatedfromrag-1/miceinjected18dearlierwitheithera1:1mixofpuri-
fiedsplenicCD4+CD25wt(Ly5.1+andLy5.2+)orwt(Ly5.1+)andc-rel/(Ly5.2+)TcellswerestainedwithantibodiesspecificforCD4,CD8,CD45.1
(Ly5.1)andFoxp3.Thedatacomparesthepercentagesofwt(Ly5.1+andLy5.2+,squaresandcircles,respectively)andc-rel/(Ly5.2+,triangles)
CD4+Foxp3+cellsdetectedinthemesentericlymphnodesofindividualmicereceivingeachmixtureofcells.ThedatawereanalyzedusingapairedTtest
andisrepresentativeoftwoindependentexperiments,withaminimumoffivemiceineachrecipientgroup.Horizontalbarsrepresentthemeanvaluesof
thedata.ErrorbarsrepresentSD.
Figure S5. Foxp3 expression in populations of purified peripheral nT reg cells and converted CD4+CD25 T cells.(A)Purifiedwtandc-rel/
populationsofsplenicCD4+CD25+TcellswerestainedforFoxp3expression.RepresentativepurityofthesortedpopulationsandthelevelsofFoxp3ex-
pressionareshown.Thedataarerepresentativeofsixindependentexperiments.(B)TypicalpurityinGFP+populationsofwtandc-rel/CD4+CD25T
cellstransducedwithFoxp3/GFPretrovirus.WesternblottingdemonstratesFoxp3expressioninthesepopulations.Thedataarerepresentativeoffour
independentexperiments.(C)PurityofFACS-purifiedwtandc-rel/CD4+CD25+TcellsgeneratedinculturebyTGF-plusIL-2stimulation.Foxp3ex-
pressioninthesepopulationsisalsoshown.Thedataarerepresentativeoffourindependentexperiments.
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Figure S6. T reg cell control of antigen-specific effector T cell proliferation in c-rel/ mice.(A)Anti-CD25antibodydepletionofTregcells
augmentstheantigen-inducedproliferationofCD8+OT-ItransgenicTcells.2×106purifiedCD8+splenicandlymphnodeTcells(V2+)fromCD45.1+
OT-Imicewereinjectedintowtmicethatwereeitheruntreated(sixmice)orpretreatedwithfour1-mgdosesofanti-CD25mAbpermouse(fivemice)
deliveredovera9-dperiod.Atthetimeofcelltransfer,eachmousewasimmunizedwithacombinationofOVA/QuilA(100µgOVAand20µgQuilA;
Steptoeetal.2007.J. Immunol.178:2094–2103).7dlater,thenumberofCD45.1+V2+CD8+Tcells,plusthefrequencyofCD25+Foxp3+Tcells(asaper-
centageofCD4+cells)inthedraininginguinallymphnodesofmiceweredeterminedusingaflowcytometrybeadassay(Steptoeetal.2007.J. Immunol.
178:2094–2103).Thedataarerepresentativeoftwoindependentexperiments.(B)ResidualTregcellnumbersinc-rel/micelimittheOVA-dependent
expansionofOT-ICD8+Tcells.wtandc-rel/mice(bothCD45.2+)injectedwithequalnumbers(2×106)ofV2+OT-ICD8+Tcellspurifiedfromthe
spleenandlymphnodewereimmunizedwithOVA/QuilAandthen,7dlater,inguinallymphnodeCD45.1+V2+CD8+andCD4+CD25+Foxp3+Tcellswere
quantifiedasdescribedinA.Thedataobtainedfromindividualmiceinthisexperimentisrepresentativeoftwoindependentexperiments.Inbothexperi-
ments,sixwtandsixc-rel/micewereusedineachexperimentalgroup.Horizontalbarsrepresentthemeanvaluesofthedata.
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Table S1. NumbersofCD4+CD25+,CD4+CD25+Foxp3+,andCD4+CD25Foxp3+cellsinthethymusandspleenof2-,5-,and28-
d-oldwtandc-rel/mice
Cell type and day Thymus Spleen
WT c-Rel/ WT c-Rel/
Mean SEM Mean SEM Mean SEM Mean SEM
CD4SP CD25+
 D2 23,010 2,378 24,411 3,620 341 42 181 34
 D5 22,860 5,699 6,672 1,798 22,829 3,813 4,965 1,820
 D28 259,702 47,956 106,630 7,523 650,397 53,711 211,402 12,770
CD4SP CD25+Foxp3+
 D2 576 159 29 12 45 9 0 0
 D5 3,260 595 291 53 16,142 3,099 1,180 602
 D28 102,234 14,509 29,542 1,264 694,062 43,890 176,034 11,065
CD4SP CD25Foxp3+
 D2 934 231 81 15 132 33 8 4
 D5 3,599 651 825 159 4,893 658 784 310
 D28 96,504 10,221 30,710 4,633 346,423 22,407 36,023 3,701
MeanreferstothemeannumbersofCD4+CD25+,CD4+CD25+Foxp3+,andCD4+CD25Foxp3+thymocytesandsplenicTcells(±SEM)in2-,5-,and28-d-oldwtandc-rel/
mice.Thedatawerecompiledintwoindependentexperimentsfromatotalofn=10–20forD2andD5samplesandn=5forD28samples.
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Table S2. Sequencesoftheprimersusedfordeterminingquantitativereal-timePCRanalysisofgeneexpressioninwtandc-
rel/CD4+CD25andCD4+CD25+thymocytesandsplenicTcells
Name Primer sequence
mUBC forward 5-AAGAGAATCCACAAGGAATTGAATG-3
mUBC reverse 5-CAACAGGACCTGCTGAACACTG-3
mFoxp3 forward 5-GGCCCTTCTCCAGGACAG-3
mFoxp3 reverse 5-GCTGATCATGGCTGGGTTGT-3
mCD25 forward 5-AGGTCAGACAGAGCCATTTTGAGT-3
mCD25 reverse 5-CCGTGTCCCCACAAAAGATATATTT-3
mIL-2 forward 5-CCTGAGCAGGATGGAGAATTACA-3
mIL-2 reverse 5-TCCAGAACATGCCGCAGAG-3
mGITR forward 5-CCACTGAGCAATACGGCCATT-3
mGITR reverse 5-CAGCTGCCATATGTGCAGGC-3
mCtla4 forward 5-GGGCTCAGTTGCATAAACCGA-3
mCtla4 reverse 5-ACACTGCCAGCTTTTGGTTTCC-3
mIL-7 forward 5-CCTTGCTTTTTCCAGCCACG-3
mIL-7 reverse 5-GGCATGGCTACCACACATGC-3
mIL-10 forward 5-TGCCAAGCCTTATCGGAAATG-3
mIL-10 reverse 5-CCCAGGGAATTCAAATGCTCC-3
mIL-15 forward 5-GCAAGGAATGTGAGGAGCTGG-3
mIL-15 reverse 5-CGCATGCAGTCAGGACGTGT-3
mTGFb forward 5-ACCCCCACTGATACGCCTGA-3
mTGFb reverse 5-GCGCTGAATCGAAAGCCCT-3
mOX40 forward 5-TTGTACCTGCTCCGGAAGGC-3
mOX40 reverse 5-TGTGCGTCTGTGTGTTCCTCC-3
m41BB forward 5-TGTCCACAGGAAGAAGAAGGAGG-3
m41BB reverse 5-CTCGGTTTCGGCCC ACAC-3
mCD40L forward 5-AATCGGGAGCCTTCGAGTCA-3
mCD40L reverse 5-CTGTGGGTATTTGCCGCCTT-3
mCD39 forward 5-TTTCCTTGGGGTCACTCAAC-3
mCD39 reverse 5-AGGCCATGAGAGTTGTGAGC-3
mCD73 forward 5-CCAAGACAGTCCTGTGACCA-3
mCD73 reverse 5-AACCAACATGTTCCCTGTCC-3
mIL-12p35 forward 5-TCATAAGAGTCAGGTGGTCTTGG-3
mIL-12p35 reverse 5-GAGGTAGCTGTGCCACCTTT-3
mEbi3 forward 5-GGCCTGTCCTGAGTCTGAAT-3
mEbi3 reverse 5-CACAGGGTTGGAAATTGAGG-3
mICOS forward 5-CTGGCCAGGAAAACAAACAT-3
mICOS reverse 5-CAAGCGCTTCTGTTGTGAAG-3
mCD127 forward 5-TACACAGTGCAAACCGCTCG-3
mCD127 reverse 5-GCAGGTACTCAGATTTCTAGCCAGG-3
mMAP3K8 forward 5-TCTTTGAGCCTTGGTTGGTC-3
mMAP3K8 reverse 5-TCACTAGTGGCCTGCTGTCA
mCREM forward 5-AGGACAACAGCAGGGCTCTA
mCREM reverse 5-CCTCTAACCTCTTCCCCTGG
mIrf4 forward 5-GGCTTCACAATCTTCAAGGTGG
mIrf4 reverse 5-CGCATGGGAGCAGAGGG
mZEB1 forward 5-GCTTTCTGCCACACATTTAGACTCTTTGAAAA
mZEB1 reverse 5-CATATTTTCAAAGAGTCTAAATGTGTGGCAGA
mId1 forward 5-AGCAGCAGGTGAACGTCCTG
mId1 reverse 5-CACCTTGCTCACTTTGCGGT
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Table S2. Sequencesoftheprimersusedfordeterminingquantitativereal-timePCRanalysisofgeneexpressioninwtandc-
rel/CD4+CD25andCD4+CD25+thymocytesandsplenicTcells(Continued)
Name Primer sequence
mBcl2l1 forward 5-CCCAGAGACTGACAGCCTGA
mBcl2l1 reverse 5-TGTAGGGTGAGGGGAGAGGA
mBcl2 forward 5-TCTCGTCGCTACCGTCGTGA
mBcl2 reverse 5-AAGAGTTCCTCCACCACCGTG
mcRel forward 5-TTACCAGAAATGCCCAGGTC
mcRel reverse 5-AGGCCCTTCTAGGAATGGAA
mRelA forward 5-TTCCCAATGGTCTCTCAGGA
mRelA reverse 5-GTCGCTGTCAGCACCTTAGGA
mNF-kB1 forward 5-TCTAGCAATCATGGCGCTCG
mNF-kB1 reverse 5-CAACACAAAGCAAATGTGATCCAG
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